Wall Street Journal January 16, 2019
Global health groups that buy and distribute medicines are a sure bet for saving lives, but their government funding is now in danger, and even the biggest philanthropies can’t fill the gap
Technology is a boom-or-bust business, but it’s mostly busts. I’ve always assumed that 10% of my technology investments will succeed—and succeed wildly. The other 90% I expect to fail.
When I made the transition from my first career at Microsoft to my second career in philanthropy, I didn’t think that my success rate would change much. I was now putting money into new ways to reduce poverty and disease. Discovering a new vaccine, I figured, would be just as hard as discovering the next tech unicorn. (Vaccines...
Today's Sponsors
Today's Sponsor